Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor

Aysegul Gorur, Miguel Patiño, Ted Shi, German Corrales, Hideaki Takahashi, Roberto Rangel, Frederico O. Gleber-Netto, Curtis Pickering, Jeffrey N. Myers, Juan P. Cata

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry